/PRNewswire/ At the 2023 ASCO annual meeting, investigators from OneOncology s clinical team will present Oral Abstracts using real-world data to evidence.
Greenwich LifeSciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have. | December 29, 2022